Document Detail

Stage III Melanoma in the Axilla: Patterns of Regional Recurrence After Surgery With and Without Adjuvant Radiation Therapy.
MedLine Citation:
PMID:  23773393     Owner:  NLM     Status:  In-Data-Review    
PURPOSE: To describe the anatomic distribution of regionally recurrent disease in patients with stage III melanoma in the axilla after curative-intent surgery with and without adjuvant radiation therapy.
METHODS AND MATERIALS: A single-institution, retrospective analysis of a prospective database of 277 patients undergoing curative-intent treatment for stage III melanoma in the axilla between 1992 and 2012 was completed. For patients who received radiation therapy and those who did not, patterns of regional recurrence were analyzed, and univariate analyses were performed to assess for potential factors associated with location of recurrence.
RESULTS: There were 121 patients who received adjuvant radiation therapy because their clinicopathologic features conferred a greater risk of regional recurrence. There were 156 patients who received no radiation therapy. The overall axillary control rate was 87%. There were 37 patients with regional recurrence; 17 patients had received adjuvant radiation therapy (14%), and 20 patients (13%) had not. The likelihood of in-field nodal recurrence was significantly less in the adjuvant radiation therapy group (P=.01) and significantly greater in sites adjacent to the axilla (P=.02). Patients with high-risk clinicopathologic features who did not receive adjuvant radiation therapy also tended to experience in-field failure rather than adjacent-field failure.
CONCLUSIONS: Patients who received adjuvant radiation therapy were more likely to experience recurrence in the adjacent-field regions rather than in the in-field regions. This may not simply reflect higher-risk pathology. Using this data, it may be possible to improve outcomes by reducing the number of adjacent-field recurrences after adjuvant radiation therapy.
Mark B Pinkham; Matthew C Foote; Elizabeth Burmeister; Janine Thomas; Janelle Meakin; B Mark Smithers; Bryan H Burmeister
Related Documents :
24211123 - Re-irradiation with interstitial pulsed-dose-rate brachytherapy for unresectable recur...
23428983 - Prognosis of choroidal melanoma and the result of ruthenium brachytherapy combined with...
15731453 - How science survived: medieval manuscripts' "demography" and classic texts' extinction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  86     ISSN:  1879-355X     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2013-06-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  702-8     Citation Subset:  IM    
Copyright Information:
Crown Copyright © 2013. Published by Elsevier Inc. All rights reserved.
Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Australia; University of Queensland, Brisbane, Australia. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based t...
Next Document:  Dosimetric impact of the interplay effect during stereotactic lung radiation therapy delivery using ...